Biblio
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B Cell Lymphoma. Cancer Discov. 2024.
The proteogenomic subtypes of acute myeloid leukemia. Cancer Cell. 2022.
PRPF8-mediated dysregulation of hBrr2 helicase disrupts human spliceosome kinetics and 5´-splice-site selection causing tissue-specific defects. Nat Commun. 2024;15(1):3138.
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy. Cancer Cell. 2024.
ROBO3s: a novel ROBO3 short isoform promoting breast cancer aggressiveness. Cell Death Dis. 2022;13(9):762.